New prostate cancer vaccine makes it through Phase Ia trial

A company called OncBioMune Pharmaceuticals has announced initial data from a Phase Ia/Ib clinical trial of a new form of vaccine in the treatment of men with progressive prostate cancer who meet the following criteria: … READ MORE …